Introduction: John Gofman and the early years at the Donner Laboratory.

J Clin Lipidol

Cardiovascular Research Institute, University of California San Francisco, 513 Parnassus Ave, San Francisco, CA 94143-0130.

Published: May 2007

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacl.2007.03.003DOI Listing

Publication Analysis

Top Keywords

introduction john
4
john gofman
4
gofman early
4
early years
4
years donner
4
donner laboratory
4
introduction
1
gofman
1
early
1
years
1

Similar Publications

Introduction: Frozen section (FS) is often performed to confirm negative margins during pancreaticoduodenectomies (PD). This incurs significant cost, despite lack of evidence of survival benefit. We sought to determine the frequency of positive FS during PD, associated costs per positive margin identified, and association with locoregional recurrence (LRR) and overall survival (OS).

View Article and Find Full Text PDF

Introduction: Psoriasis (PsO), psoriatic arthritis (PsA), and axial spondyloarthritis (axSpA) may confer an increased risk for cardiovascular (CV) disease, including major adverse cerebro-cardiovascular events (MACE), deep vein thrombosis (DVT), and pulmonary embolism (PE). Patients with these conditions are often exposed for extended time periods to biologics, such as ixekizumab (IXE). Therefore, understanding the risk of CV events, especially MACE, in patients with PsO, PsA, and axSpA exposed to IXE is important.

View Article and Find Full Text PDF

Optimizing retention strategies for opioid use disorder pharmacotherapy: The retention phase of the CTN-0100 trial (RDD).

Contemp Clin Trials

January 2025

New York State Psychiatric Institute, 1051 Riverside Dr., New York, NY 10032, USA; Columbia University Irving Medical Center, 630 West 168(th) St., New York, NY 10032, USA. Electronic address:

Introduction And Background: The three medications approved to address OUD are effective in decreasing opioid use and morbidity and mortality; however, their utility is limited by high rates of dropout from treatment. The CTN-0100 trial will develop an evidence base for strategies to improve retention on buprenorphine and extended-release naltrexone.

Research Design And Methods: The National Drug Abuse Treatment Clinical Trials Network (CTN) study CTN-0100, "Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy" (RDD), is a multicenter, randomized, non-blinded trial enrolling more than a thousand patients from 18 community-based substance use disorder treatment programs.

View Article and Find Full Text PDF

Introduction: Early detection of neurodegeneration is essential for optimizing interventions. The highly reproducible progression of neurodegeneration in the decrepit () mouse allows investigation of early biomarkers and mechanisms of brain injury.

Methods: Using high-frequency ultrasound, the common carotid arteries of female and male and control mice were imaged longitudinally at time points bracketing the disease progression (50, 75, and 125 days of age) ( = 6 mice/group/sex).

View Article and Find Full Text PDF

Values of Life: 40 years of The Value of Life.

Camb Q Healthc Ethics

January 2025

Professor of Bioethics, University of Manchester, UK Centre for Social Ethics and Policy, University of Manchester, Manchester M13 9PL, UK.

This special section brings together international scholars celebrating the 40 anniversary of John Harris' book, (1985), and John Harris and his contributions to the field of bioethics more generally.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!